UFE vs Hysterectomy: Comparing Your Fibroid Treatment Options
Both UFE and hysterectomy are effective treatments for symptomatic fibroids, but they differ significantly in approach, recovery, and outcomes. Understanding these differences can help you and your specialist make an informed decision about the best treatment for your circumstances.
Head-to-Head Comparison
| UFE | Hysterectomy | |
|---|---|---|
| Type of Procedure | Minimally invasive (image-guided) | Major surgery |
| Anaesthesia | Conscious sedation | General anaesthesia |
| Incision | Tiny puncture (wrist or groin) | Abdominal or vaginal |
| Hospital Stay | Overnight (1 night) | 2-5 days |
| Recovery Time | 1-2 weeks | 6-8 weeks |
| Uterus Preserved | Yes | No — uterus is removed |
| Fertility | Possible (under investigation) | Not possible |
| Symptom Improvement | 85-90% | 100% (fibroids cannot recur) |
| Recurrence Risk | Low (5-10%) | None |
| Complications Rate | Low | Higher (as with any major surgery) |
| Blood Transfusion Risk | Very rare | Occasional |
When UFE May Be Preferred
UFE is often the preferred option for women who wish to preserve their uterus, whether for personal, cultural, or fertility-related reasons. Because the uterus remains intact, many women feel that UFE better aligns with their values and goals.
The shorter recovery period is another significant advantage. Most women return to work and normal activities within 1-2 weeks after UFE, compared to 6-8 weeks after hysterectomy. This makes UFE particularly suitable for women who cannot take extended time away from work or family responsibilities.
UFE avoids the risks associated with general anaesthesia and major surgery, including the risks of wound infection, adhesion formation, and blood loss. As a minimally invasive procedure performed under sedation, UFE has a lower overall complication rate.
UFE is also effective for treating multiple fibroids simultaneously, regardless of their size or location within the uterus. All fibroids are treated in a single procedure, whereas surgical removal may not address every fibroid present.
When Hysterectomy May Be Necessary
Hysterectomy is the only treatment that completely eliminates the possibility of fibroid recurrence, as the uterus is removed entirely. This makes it a definitive treatment for women who no longer wish to have children and want a permanent solution.
It may be recommended when fibroids are exceptionally large (for example, if the uterus extends well above the navel), when there is suspicion of uterine cancer or pre-cancerous changes, or when other conditions such as adenomyosis or endometriosis are also present and would benefit from surgical management.
In cases where previous treatments, including UFE or myomectomy, have not provided adequate symptom relief, hysterectomy may be considered as a next step. Your gynaecologist will discuss whether hysterectomy is the most appropriate option for your specific situation.
Recovery Comparison
Recovery is one of the most significant differences between UFE and hysterectomy. After UFE, most patients are discharged the morning after the procedure and return to normal activities within 1-2 weeks. The main post-procedure symptoms are cramping and fatigue, which typically resolve within the first week.
After hysterectomy, patients typically remain in hospital for 2-5 days and require 6-8 weeks for full recovery. During this time, activities such as driving, lifting, and exercise are restricted. The recovery period can be challenging, particularly for women with caring responsibilities or demanding work commitments.
Studies show that patient satisfaction with recovery is consistently higher for UFE, with women appreciating the ability to return to their normal routine quickly. For a detailed guide to UFE recovery, see our UFE recovery page.
Long-Term Outcomes
The EMMY trial, the largest randomised controlled trial comparing UFE and hysterectomy, published 10-year follow-up data showing that both treatments result in high levels of patient satisfaction. Quality of life improvements were comparable between the two groups.
After UFE, fibroids typically shrink by 40-60% in volume over the first 6-12 months. Symptom improvement is seen in 85-90% of patients. Approximately 20-25% of UFE patients may require additional treatment over a 10-year period, which may include a repeat UFE or, in some cases, hysterectomy.
Hysterectomy provides a permanent solution with no possibility of fibroid recurrence. However, it carries the long-term implications of uterus removal, including the inability to become pregnant and the potential psychological impact for some women.
Making the Right Decision
The choice between UFE and hysterectomy is deeply personal and depends on your individual circumstances, priorities, and values. There is no single right answer, and both treatments have their place in the management of fibroids.
At the North London Fibroid Clinic, our unique model of interventional radiologists and gynaecologists working together means you will receive a balanced, unbiased assessment of all your options. We believe in shared decision-making and will take the time to answer your questions and help you feel confident in your choice.
If you have been told that hysterectomy is your only option, we would encourage you to seek a second opinion. Many women who have been recommended hysterectomy are in fact suitable candidates for UFE. A consultation with our specialist team can help clarify your options.
Frequently Asked Questions
References
- de Bruijn AM, et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. American Journal of Obstetrics and Gynecology, 2016.
- NICE Guideline [IPG367] — Uterine artery embolisation for fibroids. National Institute for Health and Care Excellence.
- Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database of Systematic Reviews.
- Edwards RD, et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine, 2007.
Explore Your Treatment Options
Book a consultation with our specialist team for a personalised assessment
Or call us: 01305 608250